Use of inhaled corticosteroids and the risk of depressive symptoms in patients with chronic obstructive pulmonary disease
A. Jordan (Copenhagen N, Denmark), P. Sivapalan (Copenhagen N, Denmark), J. Ëklof (Copenhagen N, Denmark), J. Vestergaard (Copenhagen N, Denmark), H. Meteran (Copenhagen N, Denmark), M. Saeed (Copenhagen N, Denmark), T. Biering-Sørensen (Copenhagen N, Denmark), A. Løkke (Copenhagen N, Denmark), F. Knop (Copenhagen N, Denmark), N. Seersholm (Copenhagen N, Denmark), J. Jensen (Copenhagen N, Denmark)
Source: Virtual Congress 2021 – Lung disease burden and management
Session: Lung disease burden and management
Session type: E-poster
Number: 2151
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Jordan (Copenhagen N, Denmark), P. Sivapalan (Copenhagen N, Denmark), J. Ëklof (Copenhagen N, Denmark), J. Vestergaard (Copenhagen N, Denmark), H. Meteran (Copenhagen N, Denmark), M. Saeed (Copenhagen N, Denmark), T. Biering-Sørensen (Copenhagen N, Denmark), A. Løkke (Copenhagen N, Denmark), F. Knop (Copenhagen N, Denmark), N. Seersholm (Copenhagen N, Denmark), J. Jensen (Copenhagen N, Denmark). Use of inhaled corticosteroids and the risk of depressive symptoms in patients with chronic obstructive pulmonary disease. 2151
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Frequency of depressive syndrome in patients with bronchial asthma and chronic obstructive pulmonary disease Source: Virtual Congress 2021 – Pulmonary rehabilitation in clinical conditions Year: 2021
Inhaled corticosteroids and the risk of a first exacerbation in COPD patients Source: Eur Respir J 2004; 23: 692-697 Year: 2004
Dyspnoea, depression and anxiety in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 55s Year: 2001
Early versus late pulmonary rehabilitation on anxiety and depression in chronic obstructive pulmonary disease patients with acute exacerbations Source: Annual Congress 2012 - The latest insights in pulmonary rehabilitation Year: 2012
The efficacy and treatment length of oral corticosteroids in patient with acute exacerbation of chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 295s Year: 2005
Evaluation of bronchodilator responses in chronic obstructive pulmonary disease patients Source: Eur Respir J 2002; 20: Suppl. 38, 247s Year: 2002
Use of metoprolol succinate in patients with cardiovascular diseases associated with asthma or chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 502s Year: 2006
Determinants of depression at exacerbation in chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 557s Year: 2007
Audit of inhaled corticosteroid prescription in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2010 - COPD: management Year: 2010
Effect of systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 624s Year: 2006
Osteoporosis risk assessment in elderly male patients with COPD who use inhaled corticosteroids Source: Annual Congress 2006 - COPD therapy Year: 2006
Smoking and dyspnea severity in patients with chronic obstructive pulmonary disease Source: International Congress 2017 – Passive smoking and epidemiology Year: 2017
Inhaled corticosteroids and hospitalisation due to exacerbation of COPD Source: Eur Respir J 2003; 22: 286-289 Year: 2003
Prevalence of anxiety and depression in 196 patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2012 - COPD comorbidities I Year: 2012
Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD) and COPD concomitant with bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 521s Year: 2004
Assessment of treatment efficiency in patients with chronic obstructive pulmonary disease combined with gastroesophageal reflux disease during treatment with melatonin Source: International Congress 2014 – Clinical presentations Year: 2014
Clinical effectiveness of nebulized budesonide in the treatment of acute asthma and exacerbations of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 146s Year: 2001
The efficacy of formoterol in patients with chronic obstructive pulmonary disease (COPD) is not influenced by concomitant corticosteroid use Source: Eur Respir J 2001; 18: Suppl. 33, 515s Year: 2001
Assessment of nicotine dependence in healthy people and patients with chronic pulmonary obstructive disease or bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 134s Year: 2002
Effects of inhaled corticosteroids on airway inflammations of different types in patients with chronic obstructive pulmonary disease or asthma in stable phase Source: Annual Congress 2009 - Aspects of clinical asthma Year: 2009